A Single-Center Pilot Validation Study of a New Chronic GVHD Skin Scoring System

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 6, 2007, Pages 715-723

  Greinix, Hildegard T ^a   Pohlreich, David ^a   Maalouf, Jacqueline ^c   Soukup, Peter ^c   Supper, Volker ^a   Kalhs, Peter ^a   Knobler, Robert M ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

^c INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Chronic graft versus host disease; Skin assessment; Validation study

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADULT; ARTICLE; BODY SURFACE; CALCULATION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ERYTHEMA; FEASIBILITY STUDY; FEMALE; HUMAN; INTRARATER RELIABILITY; MALE; OBSERVER VARIATION; PHYSICIAN; PILOT STUDY; PROSPECTIVE STUDY; REPRODUCIBILITY; SCLERODERMA; SCORING SYSTEM; SKIN DISEASE; SKIN EXAMINATION; VALIDATION STUDY;

ADULT; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; SKIN TESTS;

EID: 34248634893     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.02.007     Document Type: Article

References (22)

1. Lee S.J., Vogelsang G., Gilman A., et al. A survey of diagnosis, management and grading of chronic GVHD. Biol Blood Marrow Transplant 8 (2002) 32-39
2. Worel N., Biener D., Kalhs P., et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 30 (2002) 619-626
3. Nash R.A., Antin J.H., Karanes C., et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 96 (2000) 2062-2068
4. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339 (1998) 1565-1577
5. Collins R.H., Shpilberg O., Drobyski W.R., et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 15 (1997) 433-444
6. Sullivan K.M. Graft vs host disease. In: Blume K.G., Forman S.J., and Appelbaum F.R. (Eds). Thomas' hematopoietic cell transplantation, 3rd ed (2004), Blackwell Publishing, Oxford 635-664
7. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft vs host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69 (1980) 204-217
8. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 11 (2005) 945-955
9. Akpek G., Lee S.J., Flowers M.E., et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 102 (2003) 802-809
10. Rodnan G.P., Lipinski E., and Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22 (1979) 130-140
11. Kahaleh M.B., Sultany G.L., Smith E.A., et al. A modified scleroderma skin scoring method. Clin Exp Rheumatol 4 (1986) 367-369
12. Flowers M.E.D., Van Besien K., Apperley J., et al. A randomized single-blind study of extracorporeal photopheresis with UVADEX plus conventional therapy (CT) compared to CT alone in chronic GVHD. Blood 108 (2006) 758 (abstract)
13. Shrout P.E., and Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86 (1979) 420-428
14. McGraw K.O., and Wong S.P. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1 (1996) 30-46
15. Vogelsang G.B. How I treat chronic graft-versus-host disease. Blood 97 (2001) 1196-1201
16. Lee S.J., Klein J.P., Barrett A.J., et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 100 (2002) 406-414
17. Shulman H.M., Kleiner D., Lee S.J., et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 12 (2006) 31-47
18. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group Report. Biol Blood Marrow Transplant 12 (2006) 252-266
19. Clemens P.J., Lachenbruch P.A., and Seibold J.R. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20 (1993) 1892-1896
20. Gottlober P., Leiter U., Friedrich W., et al. Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography. J Euro Acad Dermatol Venereol 17 (2003) 402-407
21. Dumford K., and Anderson J.C. CT and MRI findings in sclerodermatous chronic graft vs host disease. Clin Imaging 25 (2001) 138-140
22. Martin P.J., Weisdorf D., Przepiorka D., et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 12 (2006) 491-505